Differences Between T Cell Epitopes Recognized After Immunization and After Infection
Open Access
- 15 October 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 169 (8) , 4511-4521
- https://doi.org/10.4049/jimmunol.169.8.4511
Abstract
Evidence suggests that cellular immune responses play a crucial role in the control of HIV and SIV replication in infected individuals. Several vaccine strategies have therefore targeted these CD8+ and CD4+ responses. Whether vaccination induces the same repertoire of responses seen after infection is, however, a key unanswered question in HIV vaccine development. We therefore compared the epitope specificity induced by vaccination to that present postchallenge in the peripheral blood. Intracellular cytokine staining of PBMC stimulated with overlapping 15/20-mer peptides spanning the proteins of SIV were measured after DNA/modified vaccinia Ankara vaccination of eight rhesus macaques. Lymphocytes from 8 animals recognized a total of 39 CD8 epitopes and 41 CD4 epitopes encoded by the vaccine. T cell responses were again monitored after challenge with SIVmac239 to investigate the evolution of these responses. Only 57% of all CD8+ T cell responses and 19% of all CD4+ T cell responses present after vaccination were recalled after infection as measured in the peripheral blood. Interestingly, 29 new CD8 epitopes and 5 new CD4 epitopes were recognized by PBMC in the acute phase. These new epitopes were not detected after vaccination, and only some of them were maintained in the chronic phase (33% of CD8 and no CD4 responses). Additionally, 24 new CD8 epitopes and 7 new CD4 epitopes were recognized by PBMC in the chronic phase of infection. The repertoire of the immune response detected in the peripheral blood after immunization substantially differed from the immune response detected in the peripheral blood after infection.Keywords
This publication has 84 references indexed in Scilit:
- Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239Journal of Virology, 2002
- A Commonly Recognized Simian Immunodeficiency Virus Nef Epitope Presented to Cytotoxic T Lymphocytes of Indian-Origin Rhesus Monkeys by the Prevalent Major Histocompatibility Complex Class I Allele Mamu-A*02Journal of Virology, 2001
- Frequency and Phenotyping of Human Immunodeficiency Virus (HIV)–Specific CD8+T Cells in HIV‐Infected Children, Using Major Histocompatibility Complex Class I Peptide TetramersThe Journal of Infectious Diseases, 2001
- Rapid Definition of Five Novel HLA-A∗3002-Restricted Human Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Epitopes by Elispot and Intracellular Cytokine Staining AssaysJournal of Virology, 2001
- A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in miceVaccine, 2000
- Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + LymphocytesScience, 1999
- Effect of T‐helper cytokine environment on specificity of T‐cell responses to mycobacterial 65 000 MW heat‐shock proteinImmunology, 1998
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- Ability of HIV to Promote a T H 1 to T H 0 Shift and to Replicate Preferentially in T H 2 and T H 0 CellsScience, 1994